Outcomes of the 6th IDEA Annual Review meeting
All the documents from the 6th IDEA Annual Review meeting can be found on this page
Keep up to date with the latest news about IDEA, including the initiative's workshops, events and publications
All the documents from the 6th IDEA Annual Review meeting can be found on this page
All the meeting documents of the workshop on the Reference Chemicals Potency List of 7 October can be found here.
In the effort towards a QRA on skin sensitization based on new approach methodologies (NAMs) instead of the LLNA, IDEA provides a multi-stakeholder forum to facilitate the generation of a guidance framework based on NAMs to identify a NESIL for fragrance ingredients (FIs).
Six years in IDEA – what is our progress in understanding and managing the pre-hapten question?
On 12 December 2018 IDEA held a Workshop on the Characterization and Categorization of allergens, at the Hotel Dominican, Brussels.
On 9 January 2019 a Joint Meeting of the IDEA Supervisory Group (SG) and the IDEA Management Team took place in London.
IDEA's work on a market surveillance study on Limonene and Linalool hydroperoxides in finished consumer products has been published in Food and Chemical Toxicology.
The European Parliament in Brussels hosts the fifth Annual Review of the IDEA Project on 25 February 2019.
IDEA experts reunited on 12 December 2018 in Brussels to continue the discussion on Characterization and Categorization (C&C) of fragrance allergens.
On Friday 19 October, 2018, IDEA hosted an Industry Symposium session at the European Society of Contact Dermatitis (ESCD) Congress in Milan, Italy.
During a 'Petit WPC' session on 7 June 2018 at the World Perfumery Congress, a panel of experts discussed how The International Dialogue for the Evaluation of Allergens (IDEA) developed a global framework for assessing fragrance sensitizers through various partnerships and collaborations.
The International Dialogue for the Evaluation of Allergens (IDEA) held a Workshop on 16-17 May looking at the replacement of animal testing in quantitative risk assessment (QRA) for skin sensitisation.